Abeona Therapeutics, Inc. (ABEO)
5.425
+0.04
(+0.65%)
USD |
NASDAQ |
Apr 27, 11:48
Abeona Therapeutics Shareholders Equity (Quarterly) : 159.22M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 527.16M |
| Plus Therapeutics, Inc. | 3.996M |
| Atossa Therapeutics, Inc. | 39.35M |
| Cell Source, Inc. | -18.54M |
| Kiora Pharmaceuticals, Inc. | 16.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 221.17M |
| Total Liabilities (Quarterly) | 61.96M |
| Debt to Equity Ratio | 0.1568 |
| Current Ratio | 6.930 |
| Net Debt Paydown Yield | -0.13% |